Aydın İsmet Hazar

Clinical Course of a Case with Sarcomatoid Renal Cell Carcinoma

Özkan Onuk, Burak Arslan, Aydın İsmet Hazar, Arif Özkan, Nusret Can Çilesiz & Barış Nuhoğlu · International Journal of Medical and Pharmaceutical Case Reports · 2016

Introduction: Renal cell carcinoma (RCC) is the most frequently observed malign neoplasm of the kidney. Its sarcomatoid variant (SRCC) is rare but aggressive. Our aim is to present the clinical course of a 51 year-old patient with SRCC, in the light of the literature. Methods: A...

Open access Research Article 10.9734/IJMPCR/2016/25900

Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer

Burak Arslan, Mehmet Fatih Akbulut, Özkan Onuk, Aydın İsmet Hazar, Arif Özkan, Cem Tuğrul Gezmiş, Buğra Çetin & Memduh Aydın · Journal of Advances in Medicine and Medical Research · 2016

Objective: To analyze potential factors affecting the outcomes of docetaxel and prednisone (DP) combination therapy in patients with castration resistant prostate cancer (CRPC). Methods: A total of 272 patients were treated with DP chemotherapy for CRPC between April 2006 and Jan...

Open access Research Article 10.9734/BJMMR/2016/25855